BusinessGeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical TherapeuticsBy Nasdaq OMXFeb 23, 2017, 12:05 PM UTC
BusinessCyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study in Elderly Patients With Acute Myeloid LeukemiaBy Nasdaq OMXFeb 23, 2017, 11:57 AM UTC
BusinessBio-Optronics® and OmniComm Systems® to Provide Top-Tier Cancer Research Institution With CTMS and EDC for Real-Time Data AccessBy Nasdaq OMXFeb 22, 2017, 1:01 PM UTC
BusinessImmune Design Receives Orphan Drug Designation for G100 Intratumoral Product CandidateBy Nasdaq OMXFeb 22, 2017, 1:00 PM UTC
BusinessGeron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial ResultsBy Nasdaq OMXFeb 22, 2017, 12:30 PM UTC
BusinessTESARO Announces Participation at Two Investor ConferencesBy Nasdaq OMXFeb 21, 2017, 9:15 PM UTC
BusinessOrganovo Publishes Data Describing Physiology of 3D Bioprinted Human Kidney Tissues for Drug Toxicity TestingBy Nasdaq OMXFeb 21, 2017, 1:05 PM UTC
BusinessAssembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to AllerganBy Nasdaq OMXFeb 21, 2017, 12:05 PM UTC
